EveryONE Medicines
Joshua Ofman MD, MSHS is a prominent leader in the medical and healthcare sectors, currently serving as the Chairman of the Board of Directors for EveryONE Medicines and the President of GRAIL. With a robust background in corporate strategy, Joshua Ofman has held significant roles at GRAIL, Inc., including Chief Medical Officer and Head of External Affairs, as well as Chief of Corporate Strategy and External Affairs. Joshua Ofman's experience at Amgen includes positions such as Senior Vice President of Global Value, Access and Policy. Academically, Joshua Ofman earned an MD from the David Geffen School of Medicine at UCLA and an MSHS in Health Services Research from the UCLA Fielding School of Public Health.
This person is not in the org chart
This person is not in any teams
EveryONE Medicines
EveryONE Medicines is committed to developing individualized precision medicines targeting genetic variants causing fatal, neurodegenerative diseases unique to just a few or even ONE patient. Momentum is building as technological advances with genomic testing and the prevalence of testing is improving rapidly to identify the rarest of rare mutations. Through a collaborative effort across all stakeholders in the treatment and diagnosis of rare genetic disease, EveryONE Medicines will bring a scalable solution to meet the needs of the individual patient who currently has limited hope.